FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3442104013 1 (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core
    3442105014 1 en Synonym Active Case insensitive SNOMED CT core
    64719019 One en Synonym Active Case insensitive SNOMED CT core
    771016011 One (qualifier value) en Fully specified name Inactive Initial character case insensitive SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Streptokinase 750000 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Botulism immunoglobulin 100 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Botulism immunoglobulin 100 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Salbutamol 400 microgram/actuation powder for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Salbutamol 400 microgram/actuation powder for inhalation Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefoperazone (as cefoperazone sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefoperazone (as cefoperazone sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Cefoperazone (as cefoperazone sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Aclarubicin 20 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Aclarubicin 20 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ticarcillin (as ticarcillin disodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Ticarcillin (as ticarcillin disodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ticarcillin (as ticarcillin disodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ceftazidime anhydrous (as ceftazidime) 6 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ceftazidime anhydrous (as ceftazidime) 6 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Mezlocillin (as mezlocillin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amoxicillin anhydrous (as amoxicillin) 40 mg/mL and clavulanic acid (as clavulanate potassium) 5.7 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 2
    Amoxicillin anhydrous (as amoxicillin) 40 mg/mL and clavulanic acid (as clavulanate potassium) 5.7 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cefaclor anhydrous (as cefaclor) 250 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefaclor anhydrous (as cefaclor) 250 mg chewable tablet Count of base of active ingredient False 1 Inferred relationship Some
    Albiglutide 30 mg powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Albiglutide 30 mg powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Ceftizoxime (as ceftizoxime sodium) 10 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ceftizoxime (as ceftizoxime sodium) 10 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Nonacog alfa 250 international unit lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Nonacog alfa 250 international unit lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Albiglutide 50 mg powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Albiglutide 50 mg powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch Has concentration strength denominator value False 1 Inferred relationship Some 3
    Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch Has concentration strength denominator value False 1 Inferred relationship Some 2
    Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Trastuzumab 440 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Trastuzumab 440 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Plicamycin 500 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Plicamycin 500 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Varicella-zoster virus antibody 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Varicella-zoster virus antibody 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Varicella-zoster virus antibody 250 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Varicella-zoster virus antibody 250 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 20 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 20 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Hydrocortisone 1.67 mg/mL rectal suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Hydrocortisone 1.67 mg/mL rectal suspension Count of base of active ingredient False 1 Inferred relationship Some
    Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Alprostadil 10 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Alprostadil 10 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Dyclonine hydrochloride 10 mg/mL cutaneous solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Dyclonine hydrochloride 10 mg/mL cutaneous solution Count of base of active ingredient False 1 Inferred relationship Some
    Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sodium chloride 9 mg/mL solution for ocular irrigation Count of base of active ingredient False 1 Inferred relationship Some
    Sodium chloride 9 mg/mL solution for ocular irrigation Has concentration strength denominator value False 1 Inferred relationship Some 1
    Drotrecogin alfa 5 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Drotrecogin alfa 5 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cefaclor anhydrous (as cefaclor) 37.4 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cefaclor anhydrous (as cefaclor) 37.4 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cilastatin (as cilastatin sodium) 500 mg and imipenem anhydrous (as imipenem) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cilastatin (as cilastatin sodium) 500 mg and imipenem anhydrous (as imipenem) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 2
    Levofloxacin anhydrous (as levofloxacin) 15 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Levofloxacin anhydrous (as levofloxacin) 15 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Peginterferon alfa-2b 150 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Peginterferon alfa-2b 150 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Lutropin alfa 75 unit powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Lutropin alfa 75 unit powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Nonacog alfa 1000 international unit lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Nonacog alfa 1000 international unit lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Cefalexin anhydrous (as cefalexin) 50 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Cefalexin anhydrous (as cefalexin) 50 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 3
    Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Erythromycin (as erythromycin lactobionate) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Erythromycin (as erythromycin lactobionate) 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Nonacog alfa 500 international unit lyophilised powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Nonacog alfa 500 international unit lyophilised powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 97 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start